• Research Blog

    These blogs are compiled by trainee paediatric gastroenterologists,  all actively involved in research into paediatric inflammatory bowel disease.  We thank Dr Tony Wiskin for organising these blogs over the last couple of years and Dr Protima Amon for taking over from him.

    • Dr Protima Amon, Barts & The Royal London Hospital (CICRA Fellow)
    • Dr Tracy Coelho, University of Southampton (CICRA Fellow)
    • Dr Fiona Cameron, University of Edinburgh (ex. CICRA Fellow)

    Links are provided to the free abstracts of each article, but full access may require a fee for those without institutional privileges.

    Many thanks to all the doctors who have produced regular blogs of interest to all those affected by Inflammatory Bowel Disease. 

    Latest Blog

    05.06.16 Biosimilar Drugs in Paediatric Inflammatory Bowel Disease

    Biological medicines, such as infliximab, have been effectively used in inflammatory bowel disease (IBD) and other autoimmune inflammatory conditions with high remission rates. As the name suggests, these compounds are derived from a biological source and have a significantly larger molecular structure as compared to the standard medications. When patents for standard drugs expire, generic products […]

    05.06.16
    Impact of Clostridium Difficile Infection on Inflammatory Bowel Disease
    12.03.15
    What makes some patients with Crohn’s different?
    11.25.15
    Immune cells save our good bacteria: New research reveals how T cells are taught not to attack our beneficial microbiota
    09.30.15
    A new oral drug for treating Crohn’s disease?
    08.26.15
    Can we use gut bacteria to predict how well we are?
    07.22.15
    Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn?
    07.07.15
    Potential new treatment in Crohn’s disease – too good to be true?
    06.17.15
    Treatment with Infliximab may also be making your bones stronger
    05.13.15
    Viruses in IBD – the new front-line in microbiota research?